JENNIFER BROWN: Open Payments
NPI 1215421888 · SPARTANBURG, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$419 in 16 payments from 9 companies in 2025. Trend: 2023 $663 · 2024 $615 · 2025 $419
Food & beverage: $419
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $119 |
| Eisai Inc. | 3 | $84 |
| Daiichi Sankyo Inc. | 2 | $56 |
| Merck Sharp & Dohme LLC | 2 | $44 |
| AtriCure, Inc. | 1 | $33 |
| Astellas Pharma US Inc | 1 | $25 |
| Genmab U.S., Inc. | 1 | $25 |
| AstraZeneca Pharmaceuticals LP | 1 | $19 |
| GlaxoSmithKline, LLC. | 1 | $14 |
Products named: ELAHERE, Lenvima, Enhertu, KEYTRUDA, EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX, Veozah, Tivdak, LYNPARZA.
Industry payments across SC — which companies pay providers there.
